Alpha memo: resveratrol exercise training translation boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Verify the ~4.1 mmHg MAP increase figure against Receipt 2's full text or abstract, or attribute it as 'reported in the source' rather than asserting it directly.
2. Soften the 'anchor splits by context rather than failing uniformly' framing to acknowledge that species, dose (15 mg/kg vs 250 mg/day), duration (28d vs 8wk), and population (mice vs aged men) differences confound the endpoint-family interpretation; present the endpoint split as one of several competing moderators.
3. Consider noting that Receipt 1 is from 2023 and Receipt 2 is from 2013 — a decade gap that could matter for protocol standards and reporting.

Major issues

• Receipt 2's excerpt states 'Exercise training led to a 45...' (cut off), but the memo reports 'exercise training increased MAP by ~4.1 mmHg' — this statistic cannot be verified from the provided excerpt and should be flagged or sourced. The blunting claim is well-supported by the title, but the exact ~4.1 mmHg figure is unverified against the bundle.
• The contrast framed as 'tissue vs systemic endpoint' is plausible but the memo conflates species, dose, duration, and population differences with endpoint-family differences. The 'split by context' framing somewhat overstates a clean mechanistic story from two highly heterogeneous studies.

Minor issues

• The title says 'translation boundary' but the memo could more explicitly state this is a two-receipt hypothesis-generating contrast, not an established mechanistic boundary.
• The moderator hypothesis (tissue vs systemic, plus age/training status) could be enumerated more crisply as competing explanations.
• The falsifier section is good but could distinguish between a decisive test for Receipt 2 alone versus a combined test of the endpoint-family split.

Reviewer note

This is a well-structured alpha memo that makes a clear, bounded two-receipt contrast: resveratrol appears protective in a mouse intestinal-ferroptosis model but blunts cardiovascular gains in aged men. The sources are real, recent enough, and directly support the thesis. The synthesis is good, integrating the two receipts into a coherent endpoint-family split hypothesis with explicit falsifiers. The main issues are: (1) the exact ~4.1 mmHg statistic cannot be verified from the provided excerpt, (2) the 'split by context rather than failing uniformly' framing mildly overstates what two highly heterogeneous studies can establish. The memo is honest about confounders (species, dose, duration, population) and provides actionable falsifiers. With verification of the statistic and modest softening of the mechanistic framing, this would be an accept. Currently revise.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis